Aurinia Announces 24 Week Remission Rates from the First Seven Patients in its Open Label AURION Study in Lupus Nephritis (LN) Jun 28, 2016
Aurinia Announces Presentations at the European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Meeting May 12, 2016
Aurinia Pharmaceuticals to Present at the 2016 Bloom Burton & Co. Healthcare Investor Conference Apr 28, 2016
